Tobramycin and Mucosal inflammation - a phase IV clinical study of FDA data

Summary:

Mucosal inflammation is reported as a side effect among people who take Tobramycin (tobramycin), especially for people who are male, 2-9 old, also take Ondansetron, and have Cytomegalovirus infection.

The phase IV clinical study analyzes which people have Mucosal inflammation when taking Tobramycin. It is created by eHealthMe based on reports of 3,545 people who have side effects when taking Tobramycin from the FDA, and is updated regularly.

What is Tobramycin?

Tobramycin has active ingredients of tobramycin. It is often used in cystic fibrosis. eHealthMe is studying from 3,579 Tobramycin users. Check the latest studies of Tobramycin.

What is Mucosal inflammation?

Mucosal inflammation (infection of mucous membrane) is found to be associated with 1,192 drugs and 1,241 conditions by eHealthMe. Check the latest studies of Mucosal inflammation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

3,545 people reported to have side effects when taking Tobramycin.
Among them, 33 people (0.93%) have Mucosal inflammation.

Could Tobramycin cause Mucosal inflammation?

Among these 33 people:

What is the gender of people who have Mucosal inflammation when taking Tobramycin? *

female: 16.67 %
male: 83.33 %

What is the age of people who have Mucosal inflammation when taking Tobramycin? *

What are other drugs people take besides Tobramycin? *

What are other side effects people have besides Mucosal inflammation? *

Aplastic Anemia: 17 people, 51.52%
Febrile Neutropenia (fever with reduced white blood cells): 11 people, 33.33%
Pain: 6 people, 18.18%
Erythema Multiforme (a type of hypersensitivity reaction): 5 people, 15.15%
Radiation Mucositis (inflammation of oral mucosa resulting from chemotherapeutic agents or ionizing radiation): 4 people, 12.12%
Rashes (redness): 4 people, 12.12%
Injury: 3 people, 9.09%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 9.09%
Dehydration (dryness resulting from the removal of water): 3 people, 9.09%
Dyspnea Exertional: 3 people, 9.09%

What are the existing conditions these people have? *

Cytomegalovirus Infection: 10 people, 30.30%
Bone Marrow Conditioning Regimen: 6 people, 18.18%
Lung Cancer - Non-Small Cell (lung cancer): 5 people, 15.15%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 3.03%
Febrile Neutropenia (fever with reduced white blood cells): 1 person, 3.03%
Breast Cancer Female: 1 person, 3.03%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Tobramycin and have Mucosal inflammation?

- Check whether Mucosal inflammation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tobramycin:

Tobramycin (3,579 reports)

Browse all side effects of Tobramycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Mucosal inflammation:

Mucosal inflammation (1,192 drugs)

Browse all the conditions that are associated with Mucosal inflammation:

Mucosal inflammation (1,241 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tobramycin (the active ingredients of Tobramycin) and Tobramycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.